Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
2(15%)
Results Posted
33%(3 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_2
2
15%
Ph not_applicable
11
85%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
2(15.4%)
N/ANon-phased studies
11(84.6%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(3)
Completed(9)
Terminated(1)

Detailed Status

Completed9
Recruiting2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
90.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (15.4%)
N/A11 (84.6%)

Trials by Status

completed969%
recruiting215%
not_yet_recruiting18%
terminated18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
13